Chronic stable angina pharmacotherapy to prevent MI and death in asymptomatic patients
Chronic stable angina Microchapters | ||
Classification | ||
---|---|---|
| ||
| ||
Differentiating Chronic Stable Angina from Acute Coronary Syndromes | ||
Diagnosis | ||
Alternative Therapies for Refractory Angina | ||
Discharge Care | ||
Guidelines for Asymptomatic Patients | ||
Case Studies | ||
Chronic stable angina pharmacotherapy to prevent MI and death in asymptomatic patients On the Web | ||
FDA on Chronic stable angina pharmacotherapy to prevent MI and death in asymptomatic patients | ||
CDC onChronic stable angina pharmacotherapy to prevent MI and death in asymptomatic patients | ||
Chronic stable angina pharmacotherapy to prevent MI and death in asymptomatic patients in the news | ||
Blogs on Chronic stable angina pharmacotherapy to prevent MI and death in asymptomatic patients | ||
Editors-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Cafer Zorkun, M.D., Ph.D. [2]; Associate Editors-In-Chief: John Fani Srour, M.D.; Jinhui Wu, MD.
ACC / AHA Guidelines- Pharmacotherapy to Prevent MI and Death in Asymptomatic Patients (DO NOT EDIT) [1][2]
“ |
Class I1. Aspirin in the absence of contraindication in patients with prior MI. (Level of Evidence: A) 2. Beta-blockers as initial therapy in the absence of contraindications in patients with prior MI. (Level of Evidence: B) 3. Lipid-lowering therapy in patients with documented CAD and LDL cholesterol greater than 130 mg/dL, with a target LDL of less than 100 mg/dL. (Level of Evidence: A) 4. ACE inhibitor in patients with CAD who also have diabetes and/or left ventricular systolic dysfunction. (Level of Evidence: A) Class IIa1. Aspirin in the absence of contraindications in patients without prior MI. (Level of Evidence: B) 2. Beta-blockers as initial therapy in the absence of contraindications in patients without prior MI. (Level of Evidence: C) 3. Lipid-lowering therapy in patients with documented CAD and LDL cholesterol 100 to 129 mg/dL, with a target LDL of 100 mg/dL. (Level of Evidence: C) 4. ACE inhibitor in all patients with CAD or other vascular disease. (Level of Evidence: B) |
” |
See Also
Guidelines Resources
- Guidelines on the management of stable angina pectoris: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology [3]
- The ACC/AHA/ACP–ASIM Guidelines for the Management of Patients With Chronic Stable Angina [1]
- The ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina [2]
- The 2007 Chronic Angina Focused Update of the ACC/AHA 2002 Guidelines for the Management of Patients With Chronic Stable Angina [4]
References
- ↑ 1.0 1.1 Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM et al. (1999) ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina). Circulation 99 (21):2829-48. PMID: 10351980
- ↑ 2.0 2.1 Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS et al. (2003) ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 107 (1):149-58. PMID: 12515758
- ↑ Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F; et al. (2006). "Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology". Eur Heart J. 27 (11): 1341–81. doi:10.1093/eurheartj/ehl001. PMID 16735367.
- ↑ Fraker TD, Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, Daley J et al. (2007) 2007 chronic angina focused update of the ACC/AHA 2002 Guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 Guidelines for the management of patients with chronic stable angina. Circulation 116 (23):2762-72. DOI:10.1161/CIRCULATIONAHA.107.187930 PMID: 17998462